Efficacy of Galcanezumab in Patients with Episodic Cluster Headaches and a History of Preventive Treatment Failure

被引：0
|
作者：
Plato, B. M. [1 ]
Andrews, J. [2 ]
Rettiganti, M. [2 ]
Tockhorn-Heidenreich, A. [2 ]
Bardos, J. [2 ]
Wenzel, R. [2 ]
Kuruppu, D. [2 ]
Ambrosini, A. [3 ]
机构：
[1] Norton Neurosci Inst, Louisville, KY USA
[2] Eli Lilly & Co, Indianapolis, IN 46285 USA
[3] IRCCS Neuromed, Headache Clin, Pozzilli, Molise, Italy
来源：
HEADACHE | 2020年 / 60卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：53 / 54
页数：2
相关论文
共 50 条
  • [31] Efficacy and safety of galcanezumab as chronic cluster headache preventive treatment under real world conditions: Observational prospective study
    Perez, Raquel Lamas
    Millan-Vazquez, Manuel
    Gonzalez-Oria, Carmen
    CEPHALALGIA, 2024, 44 (03)
  • [32] Real-world experience with 240 mg of galcanezumab for the preventive treatment of cluster headache
    Mo, Heejung
    Kim, Byung-Kun
    Moon, Heui-Soo
    Cho, Soo-Jin
    JOURNAL OF HEADACHE AND PAIN, 2022, 23 (01):
  • [33] Real-world experience with 240 mg of galcanezumab for the preventive treatment of cluster headache
    Heejung Mo
    Byung-Kun Kim
    Heui-Soo Moon
    Soo-Jin Cho
    The Journal of Headache and Pain, 2022, 23
  • [34] Efficacy and tolerability of fremanezumab for migraine preventive treatment in Korean patients with chronic or episodic migraine
    Kim, Byung-Kun
    Cohen, Joshua
    Kim, Sukyung
    Chang, Daeho
    Ning, Xiaoping
    Lengil, Tamar
    Janka, Lindsay
    Barash, Steve
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2021, 429 : 214 - 214
  • [35] Tolerability and safety of galcanezumab in patients with chronic cluster headache with up to 15 months of galcanezumab treatment
    Lainez, Miguel J. A.
    Schoenen, Jean
    Stroud, Chad
    Bardos, Jennifer
    Bangs, Mark
    Kemmer, Phebe
    Wenzel, Richard
    Kuruppu, Dulanji K.
    Michael Martinez, James
    Oakes, Tina M.
    HEADACHE, 2022, 62 (01): : 65 - 77
  • [36] Safety and Tolerability of Galcanezumab in Patients With Chronic Cluster Headache With Up to 15 Months of Galcanezumab Treatment
    Lainez, M. J. A.
    Schoenen, J.
    Stroud, C. E.
    Bardos, J.
    Bangs, M.
    Kemmer, P.
    Wenzel, R.
    Kuruppu, D.
    Martinez, J.
    Oakes, T. M.
    HEADACHE, 2020, 60 : 123 - 124
  • [37] Efficacy and safety of galcanezumab for preventive treatment of migraine: a systematic review and meta-analysis
    Zhao, Xiuyuan
    Xu, Xiaolin
    Li, Qingyun
    JOURNAL OF NEUROLOGY, 2021, 268 (07) : 2364 - 2376
  • [38] Efficacy and safety of galcanezumab for preventive treatment of migraine: a systematic review and meta-analysis
    Stauffer, Virginia L.
    Oakes, Tina M.
    Rettiganti, Mallikarjuna
    Day, Kathleen A.
    Camporeale, Angelo
    JOURNAL OF NEUROLOGY, 2021, 268 (05) : 1980 - 1980
  • [39] Efficacy and safety of galcanezumab for cluster headache preventive treatment: a systematic review and meta-analysis (vol 47, pg 63, 2024)
    da Silva, Marina Barbosa
    Ferreira, Domenica Baroni Coelho de Oliveira
    Mendieta, Cristian D.
    da Silva, Hamilcar Pereira
    Nogueira-Rosa, Livia Aguiar
    Moraes-Figueiredo, Nathalia
    NEUROLOGICAL RESEARCH, 2025,
  • [40] Efficacy and safety of galcanezumab for preventive treatment of migraine: a systematic review and meta-analysis
    Virginia L. Stauffer
    Tina M. Oakes
    Mallikarjuna Rettiganti
    Kathleen A. Day
    Angelo Camporeale
    Journal of Neurology, 2021, 268 : 1980 - 1980
12345